Skip to: Curated Story Group 1
healthcarebusinessreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
  • Home
  • Sections
    Business Process Outsourcing
    Compliance & Risk Management
    Consulting Service
    Facility Management Services
    Financial Services
    Healthcare Digital Marketing
    Healthcare Education
    Healthcare Procurement
    Healthcare Security
    Healthcare Staffing
    Long-Term Care Pharmacy Services
    Medical Billing
    Medical Transportation
    Practice Management Service
    Real Estate Services
    Supply Chain
    Therapy Services
  • Contributors
  • News
  • Vendors
  • Conferences
  • Awards
Welcome back to this new edition of Healthcare Business Review !!!✖
Sign In

Subscribe to our Weekly Newsletter to get latest updates to your inbox
9 AUGUST 2024Patients with these disorders die anywhere from 2 to 4 times the rate of patients without mental health and substance use disorders from diagnoses such as heart disease and diabetes, even when adjusted for socioeconomic factors. The reason is that their underlying illness prevents them from seeking medical attention or, when they do seek medical attention, they present in atypical ways. This leads to a gap in our ability to truly care for patients on a true population health level.So how can we address this and improve this? One way could be through technology. Data mining supplemented by AI could possibly pick up subtle and early signs. Prompts from an EHR could move clinicians to ask more probing questions. But the EHR prompts already exist and data mining's utility here would be limited as long as patients underreport their symptoms due to societal stigma and being limited by their illnesses. Ultimately, we need to be addressing the stigma around these illnesses in both direct and indirect ways. Both clinical and nonclinical people need to be taught that these are true medical illnesses that need medication and other interventions to treat them. While it is understood that somebody could take medications to treat their high blood pressure or high cholesterol or diabetes, things like medication-assisted treatment for substance use disorders is still frowned upon in some parts of the 12-step and addiction treatment community. That needs to change, and it can only change with educating people in healthcare as to what the actual medicine, science, and evidence show. By changing the way we speak about it to patients, we can emphasize that these are just other medications. While it might sound trite to think that changing some medical terms could make a difference, over time we will convey a different way to think about them to nonmedical people. If we think about these illnesses differently, then we treat them differently. If depression, anxiety, schizophrenia, opiate addiction, and any of a multitude of other illnesses are thought about the same way that cancer or heart disease is, it can relieve stigma and make it easier for patients to seek the help that they truly need.The goals of population health are to treat a patient across multiple times and locations to prevent illnesses from worsening earlier. This keeps the public healthier while reducing the burgeoning costs of healthcare. But if we are under treating illnesses that multiply the morbidity and mortality of our patients by several times, we can never truly achieve our goals. Ultimately it is up to us to help change how society views mental health and substance use disorders. Our patients are depending on us. PATIENTS WITH MENTAL HEALTH AND SUBSTANCE USE DISORDERS FREQUENTLY FALL THROUGH THE CRACKS IN OUR HEALTHCARE SYSTEM, NOT BECAUSE WE ARE UNAWARE OF THOSE ILLNESSES, BUT BECAUSE OF A SOCIETAL STIGMA WHICH PREVENTS THE PATIENT FROM EVER PRESENTING
< Page 8 | Page 10 >